Avanafil
Active substance: avanafil
TABLET · AVANAFIL 100 mg/1
United StatesActive
Marketing holder: Camber Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- AVANAFIL · 100 mg/1
Analogues by country
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c5-2798-7083-a33a-8c7ab200c903;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-181e-7c4f-9c8c-239136addff5,01a1209a-cce5-7c10-93c7-e5d1c2a73bde,01a1209a-cce7-7d03-9035-81a718244bc8;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 31722-441
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 31722-441 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 31722-441 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 31722-441 · Verified 2026-10-09 · open in source